Sign In
Buy AKBA
$0.97
+0.0333 (+3.56%)
At Close: Jun 03, 2026
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08:30pm, Thursday, 02'nd Apr 2020
Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company focused on the development and commercialization of therapeutics for people living with kidney disease, granted eight newly-hired
Is the Options Market Predicting a Spike in Akebia Therapeutics (AKBA) Stock?
02:00pm, Thursday, 02'nd Apr 2020
Investors need to pay close attention to Akebia Therapeutics (AKBA) stock based on the movements in the options market lately.
Is the Options Market Predicting a Spike in Akebia Therapeutics (AKBA) Stock?
02:00pm, Thursday, 02'nd Apr 2020
Investors need to pay close attention to Akebia Therapeutics (AKBA) stock based on the movements in the options market lately.
Akebia Therapeutics (NASDAQ:AKBA) Rating Increased to Buy at ValuEngine
06:42am, Thursday, 02'nd Apr 2020
Akebia Therapeutics (NASDAQ:AKBA) was upgraded by ValuEngine from a “hold” rating to a “buy” rating in a research report issued on Thursday, ValuEngine reports. AKBA has been the topic of a nu
Is the Options Market Predicting a Spike in Akebia Therapeutics (AKBA) Stock?
12:00am, Thursday, 02'nd Apr 2020Corporate Donations to Support AKF Coronavirus Emergency Fund Help Provide a Lifeline to Low-Income Kidney Patients
08:40pm, Tuesday, 31'st Mar 2020
ROCKVILLE, MD / ACCESSWIRE / March 31, 2020 / A deluge of applications from low-income dialysis and recent transplant patients depleted the American Kidney Fund's (AKF) Coronavirus Emergency Fund o
$77.54 Million in Sales Expected for Akebia Therapeutics Inc (NASDAQ:AKBA) This Quarter
08:54am, Tuesday, 31'st Mar 2020
Equities analysts expect Akebia Therapeutics Inc (NASDAQ:AKBA) to announce sales of $77.54 million for the current quarter, according to Zacks. Three analysts have made estimates for Akebia Therapeuti
Akebia Therapeutics (NASDAQ:AKBA) Stock Price Down 6.3%
10:10am, Sunday, 29'th Mar 2020
Akebia Therapeutics Inc (NASDAQ:AKBA)’s stock price dropped 6.3% during trading on Friday . The company traded as low as $7.03 and last traded at $7.05, approximately 1,594,733 shares changed hands
Prudential Financial Inc. Grows Stock Position in Akebia Therapeutics Inc (NASDAQ:AKBA)
11:00am, Saturday, 28'th Mar 2020
Prudential Financial Inc. grew its stake in Akebia Therapeutics Inc (NASDAQ:AKBA) by 14.3% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commiss
Edited Transcript of AKBA earnings conference call or presentation 10-Mar-20 1:00pm GMT
06:49am, Saturday, 28'th Mar 2020
Q4 2019 Akebia Therapeutics Inc Earnings Call
